ACTRN12616001232426
Recruiting
未知
Targeting microvascular impairment in patients with peripheral arterial disease: efficacy of lower limb revascularisation combined with supervised exercise therapy
niversity of the Sunshine Coast0 sites30 target enrollmentSeptember 5, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of the Sunshine Coast
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients scheduled for lower limb revascularisation, including open surgery (e.g. bypass), an endovascular procedure, or a hybrid procedure (e.g. endarterectomy plus angioplasty);
- •2\. Documented diagnosis of PAD based on symptoms (claudication or critical limb ischaemia), an ABI \< 0\.90, and imaging evidence of a significant (\>50%) stenosis in at least one lower\-limb arterial segment;
- •3\. Stable medication and treatment regimen (\>3 months);
- •4\. Physician\-assessed ability to undertake the intervention and exercise testing.
Exclusion Criteria
- •1\.Not able to walk independently prior to revascularisation, or walking capacity is limited by symptoms not related to PAD (including neuropathy);
- •2\.Have had or are undergoing a significant amputation (e.g. forefoot, leg) that is expected to limit ability to walk independently after surgery;
- •3\.Exercise testing is contraindicated for reasons such as unstable angina, uncontrolled hypertension (\>160/100\), limiting venous disease or uncontrolled cardiac dysrhythmias;
- •4\.Current or planned involvement in a supervised exercise rehabilitation program.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Discovering beneficial properties of ticagrelor in acute myocardialinfarctioST elevation myocardial infarction (STEMI)Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2014-005363-33-ESVU university medical center110
Active, not recruiting
Phase 1
Discovering beneficial properties of ticagrelor in acute myocardial infarctioST elevation myocardial infarction (STEMI)Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2014-005363-33-NLVU university medical center110
Completed
Not Applicable
Reducing Micro Vascular dysfunction In revascularized STEMI patients by off-target properties of ticagrelorNL-OMON44678Vrije Universiteit Medisch Centrum110
Recruiting
Not Applicable
Microvascular Complications in Patients with Type 1 DiabetesType 1 diabetes mellitusMetabolic and Endocrine - DiabetesACTRN12605000739617Sydney Diabetes Clinical Research Unit, Royal North Shore Hospital50
Active, not recruiting
Not Applicable
Targeting microvascular dysfunction in young hypertensive patients. - Targeting microvascular dysfunction in young hypertensive patients.HypertensionEUCTR2009-011638-90-GBBelfast Health and Social Care Trust